Approach to the Patient: Diagnosis and Management of Cushing's Syndrome in the Elderly - How Different Is It?
Clicks: 6
ID: 327984
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
1.5
/100
6 views
5 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #357 of 383 articles by views in the journal of clinical endocrinology & metabolism
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 383 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Cushing's syndrome in older adults is uncommon but clinically consequential. The diagnostic tests are largely the same as in younger adults, yet the clinical threshold for testing, the interpretation of biochemical results, and the therapeutic endpoint often differ. Older patients may lack classic cushingoid features and instead present with poorly controlled diabetes or hypertension, recurrent falls, rapid bone loss, proximal weakness, venous thromboembolism, cognitive decline, or an adrenal incidentaloma. These features overlap with common age-related disorders and create a dual risk: missing clinically important hypercortisolism or overdiagnosing mild biochemical abnormalities with limited clinical relevance. A practical approach begins by excluding exogenous glucocorticoid exposure, identifying progressive and discriminatory features, and selecting screening tests that account for renal function, sleep pattern, drug interactions, and the probability of non-neoplastic hypercortisolism. Late-night salivary cortisol is convenient but should be repeated and interpreted cautiously in patients with diabetes, sleep disturbance, or acute illness; urinary free cortisol may be falsely low in chronic kidney disease; and dexamethasone suppression testing requires careful review of interacting medications and, in selected cases, dexamethasone levels. Management should be based on etiology and functional status rather than chronological age. Fit older adults should generally be offered standard curative therapy, whereas vulnerable or frail patients may benefit more from staged, less invasive, or symptom-directed treatment. Preservation of mobility, cognition, independence, and quality of life should be explicit treatment goals.
| Reference Key |
openalex_W7210279080
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Yuke Liu, Ling Yi, Huiwen Tan |
| Journal | the journal of clinical endocrinology & metabolism |
| Year | 2026 |
| DOI |
10.1210/clinem/dgag361
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.